These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 22943908)
1. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study. Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908 [TBL] [Abstract][Full Text] [Related]
2. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice. Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014 [TBL] [Abstract][Full Text] [Related]
3. Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease. Nilsen LH; Melø TM; Witter MP; Sonnewald U Neurochem Res; 2014 Feb; 39(2):305-12. PubMed ID: 24338370 [TBL] [Abstract][Full Text] [Related]
5. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages. Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382 [TBL] [Abstract][Full Text] [Related]
6. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597 [TBL] [Abstract][Full Text] [Related]
7. ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease. Doert A; Pilatus U; Zanella F; Müller WE; Eckert GP J Neural Transm (Vienna); 2015 Apr; 122(4):541-50. PubMed ID: 25742870 [TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758 [TBL] [Abstract][Full Text] [Related]
9. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease. Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268 [TBL] [Abstract][Full Text] [Related]
10. Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease. Mlynárik V; Cacquevel M; Sun-Reimer L; Janssens S; Cudalbu C; Lei H; Schneider BL; Aebischer P; Gruetter R J Alzheimers Dis; 2012; 31 Suppl 3():S87-99. PubMed ID: 22451319 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal monitoring of sex-related in vivo metabolic changes in the brain of Alzheimer's disease transgenic mouse using magnetic resonance spectroscopy. van Duijn S; Nabuurs RJ; van Duinen SG; Natté R; van Buchem MA; Alia A J Alzheimers Dis; 2013; 34(4):1051-9. PubMed ID: 23321522 [TBL] [Abstract][Full Text] [Related]
12. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy. Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767 [TBL] [Abstract][Full Text] [Related]
13. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. von Kienlin M; Künnecke B; Metzger F; Steiner G; Richards JG; Ozmen L; Jacobsen H; Loetscher H Neurobiol Dis; 2005 Feb; 18(1):32-9. PubMed ID: 15649694 [TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review. Baruth JM; Wall CA; Patterson MC; Port JD Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782 [TBL] [Abstract][Full Text] [Related]
15. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS. Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581 [TBL] [Abstract][Full Text] [Related]
16. Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Oberg J; Spenger C; Wang FH; Andersson A; Westman E; Skoglund P; Sunnemark D; Norinder U; Klason T; Wahlund LO; Lindberg M Neurobiol Aging; 2008 Sep; 29(9):1423-33. PubMed ID: 17434239 [TBL] [Abstract][Full Text] [Related]
17. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Yildiz-Yesiloglu A; Ankerst DP Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850 [TBL] [Abstract][Full Text] [Related]
18. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey. García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent influence of short-term intermittent ethanol intoxication on cerebral neurochemical changes in rats detected by ex vivo proton nuclear magnetic resonance spectroscopy. Lee DW; Nam YK; Kim TK; Kim JH; Kim SY; Min JW; Lee JH; Kim HY; Kim DJ; Choe BY Neuroscience; 2014 Mar; 262():107-17. PubMed ID: 24406441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]